Risk of cancer in patients with chronic pouchitis after restorative proctocolectomy for ulcerative colitis

Colorectal Disease

Volumn 13, Issue 1, 2011, Pages 58-66

  Vento, P ^a   Lepisto A ^b   Karkkainen P ^c   Ristimaki A ^c,d   Haglund, C ^b,c   Jarvinen H J ^b  

^a KYMENLAAKSO CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

Chronic pouchitis; COX 2; Dysplasia; Ki 67

Indexed keywords

AZATHIOPRINE; CELL NUCLEUS DNA; CIPROFLOXACIN; CYCLOOXYGENASE 2; KI 67 ANTIGEN; MESALAZINE; METRONIDAZOLE; PROBIOTIC AGENT; PROTEIN P53; SIALOMUCIN; SULFOMUCIN;

ADENOCARCINOMA; ADULT; AGED; ANTIBIOTIC THERAPY; ANUS CARCINOMA; ARTICLE; CANCER RISK; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEITIS; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTESTINE ENDOSCOPY; INTESTINE VILLUS ATROPHY; LACTOBACILLUS; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

ADULT; AGED; BIOPSY; CHRONIC DISEASE; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; FLOW CYTOMETRY; GREAT BRITAIN; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; RISK FACTORS; STATISTICS, NONPARAMETRIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78650501837     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2009.02058.x     Document Type: Article

References (37)

1. Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995; 22: 120-7.
2. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994; 107: 1856-60.
3. Keränen U, Luukkonen P, Järvinen H. Functional results after restorative proctocolectomy complicated by pouchitis. Dis Colon Rectum 1997; 40: 764-9.
4. Penna C, Dozois R, Tremaine W, Sandborn W, LaRusso N, Schleck C, Ilstrup D. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38: 234-9.
5. Luukkonen P, Järvinen H, Tanskanen M, Kahri A. Pouchitis recurrence of the inflammatory bowel disease? Gut 1994; 35: 243-6.
6. Shepherd NA, Jass JR, Duval I, Moskowitz RL, Nicholls RJ, Morson BC. Restorative proctocolectiomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 1987; 40: 601-7.
7. Thompson-Fawcett MW, Marcus V, Redston M, Cohen Z, McLeod RS. Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis. Gastroenterology 2001; 121: 275-81.
8. Börjesson L, Willén R, Haboubi N, Duff SE, Hultén L. The risk of dysplasia and cancer in the ileal pouch after restorative proctocolectomy for ulcerative proctocolitis is low: A long-term term follow-up study. Colorectal Dis 2004; 6: 494-8.
9. Nilubol N, Scherl E, Bub DS et al. Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy. Dis Colon Rectum 2007; 50: 825-31.
10. Negi SS, Chaudhary A, Gondal R. Carcinoma of pelvic pouch following restorative proctocolectomy: Report of a case and review of the literature. Dig Surg 2003; 20: 63-5.
11. Laureti S, Ugolini F, D'Errico A, Rago S, Poggioli G. Adenocarcinoma below ileoanal anastomosis for ulcerative colitis: report of a case and review of the literature. Dis Colon Rectum 2002; 45: 418-21.
12. Hassan C, Zullo A, Speziale G, Stella F, Lorenzetti R, Morini S. Adenocarcinoma of the ileoanal pouch anastomosis: an emerging complication? Int J Colorectal Dis 2003; 18: 276-8.
13. Scarpa M, van Koperen PJ, Ubbink DT, Hommes DW, Ten Kate FJ, Bemelman WA. Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis. Br J Surg 2007; 94: 534-45.
14. Wong NA, Mayer NJ, MacKell S, Gilmour HM, Harrison DJ. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia. Histopathology 2000; 37: 108-14.
15. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, Stevens AC, Rubin CE. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 1992; 103: 1602-10.
16. Löfberg R, Tribukait B, Ost A, Broström O, Reichard H. Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development? Gut 1987; 28: 1100-6.
17. Steele VE, Hawk ET, Viner JL, Lubet RA. Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer. Mutat Res 2003; 524: 137-144.
18. Agoff SN, Brentnall TA, Crispin DA et al. The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol 2000; 157: 737-45.
19. Leplingard A, Brung-Lefebvre M, Guédon C, Savoye G, Dechelotte P, Lemoine F, Lebreton JP, Lerebours E. Increase in cyclooxygenase-2 and nitric oxide-synthase-2 mRNAs in pouchitis without modification of inducible isoenzyme heme-oxygenase-1. Am J Gastroenterol 2001; 96: 2129-36.
20. Riddell RH, Goldman H, Ransohoff DF et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931-68.
21. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis disease activity index. Mayo Clin Proc 1994; 69: 409-15.
22. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333-35.
23. Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Oncology 1996; 53: 182-91.
24. Hultén L, Willén R, Nilsson O, Safarani N, Haboubi N. Mucosal assessment for dysplasia and cancer in the ileal pouch mucosa in patients operated on for ulcerative colitis-a 30-year follow-up study. Dis Colon Rectum 2002; 45: 448-52.
25. Lepistö AH, Järvinen HJ. Durability of Kock continent ileostomy. Dis Colon Rectum 2003; 46: 925-8.
26. Gullberg K, Ståhlberg D, Liljeqvist L, Tribukait B, Reinholt FP, Veress B, Löfberg R. Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis. Gastroenterology 1997; 112: 1487-92.
27. Jupp J, Hillier K, Elliott DH, Fine DR, Bateman AC, Johnson PA, Cazaly AM, Penrose JF, Sampson AP. Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13: 537-46.
28. Paiotti AP, Artigiani Neto R, Forones NM, Oshima CT, Miszputen SJ, Franco M. Immunoexpression of cyclooxygenase-1 and -2 in ulcerative colitis. Braz J Med Biol Res 2007; 40: 911-8.
29. Sakuma K, Fujimori T, Hirabayashi K, Terano A. Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer. J Gastroenterol 1999; 34: 189-94.
30. Romano M, Cuomo A, Tuccillo C et al. Vascular endothelial growth factor and cyclooxygenase-2 are overexpressed in ileal pouch-anal anastomosis. Dis Colon Rectum 2007; 50: 650-9.
31. Shen B, Fazio VW, Remzi FH, Bennett AE, Lopez R, Lavery IC, Brzezinski A, Sherman KK, Lashner BA. Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders. Dig Dis Sci 2007; 52: 3321-8.
32. El Miedany Y, Youssef S, Ahmed I, El Gaafary M. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. Am J Gastroenterol 2006; 101: 311-7.
33. Remzi FH, Fazio VW, Delaney CP et al. Dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of prospective evaluation after a minimum of ten years. Dis Colon Rectum 2003; 46: 6-13.
34. Thompson-Fawcett MW, Rust NA, Warren BF, Mortensen NJ. Aneuploidy and columnar cuff surveillance after stapled ileal pouch-anal anastomosis in ulcerative colitis. Dis Colon Rectum 2000; 43: 408-13.
35. Das P, Johnson MW, Tekkis PP, Nicholls RJ. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Colorectal Dis 2007; 9: 15-27.
36. Branco BC, Sachar DB, Heimann T, Sarpel U, Harpaz N, Greenstein AJ. Adenocarcinoma complicating restorative proctocolectomy for ulcerative colitis with mucosectomy performed by cavitron ultrasonic surgical aspirator (R). Colorectal Dis. 2008; 11: 428-29.
37. Stahlberg D, Veress B, Tribukait B, Broome U. Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study. Dis Colon Rectum 2003; 46: 770-8.